Othman A. Al‐Shabanah

5.2k total citations
118 papers, 4.3k citations indexed

About

Othman A. Al‐Shabanah is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Othman A. Al‐Shabanah has authored 118 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 27 papers in Pathology and Forensic Medicine and 20 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Othman A. Al‐Shabanah's work include Chemotherapy-induced organ toxicity mitigation (21 papers), Chemotherapy-induced cardiotoxicity and mitigation (17 papers) and Nigella sativa pharmacological applications (12 papers). Othman A. Al‐Shabanah is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (21 papers), Chemotherapy-induced cardiotoxicity and mitigation (17 papers) and Nigella sativa pharmacological applications (12 papers). Othman A. Al‐Shabanah collaborates with scholars based in Saudi Arabia, Egypt and United States. Othman A. Al‐Shabanah's co-authors include Mahmoud N. Nagi, Abdullah M. Al‐Bekairi, Mohamed M. Hafez, Mohamed M. Sayed‐Ahmed, Osama A. Badary, Abdulhakeem A. Al‐Majed, Abdulaziz A. Al‐Yahya, Abdulaziz M. Aleisa, Mahmoud Mansour and Salim S. Al‐Rejaie and has published in prestigious journals such as PLoS ONE, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Othman A. Al‐Shabanah

117 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Othman A. Al‐Shabanah Saudi Arabia 40 1.2k 1.0k 891 719 491 118 4.3k
Abul Kalam Najmi India 37 1.5k 1.3× 1.2k 1.1× 451 0.5× 693 1.0× 348 0.7× 225 5.3k
Sameer N. Goyal India 35 875 0.8× 1.3k 1.3× 482 0.5× 522 0.7× 303 0.6× 127 4.1k
Jae‐Young Um South Korea 45 867 0.8× 3.5k 3.5× 666 0.7× 842 1.2× 861 1.8× 263 7.5k
Seyithan Tayşi Türkiye 37 608 0.5× 1.0k 1.0× 347 0.4× 211 0.3× 271 0.6× 166 4.5k
Siwang Wang China 37 617 0.5× 1.8k 1.8× 446 0.5× 579 0.8× 166 0.3× 169 4.2k
Joen‐Rong Sheu Taiwan 43 846 0.7× 2.1k 2.1× 242 0.3× 624 0.9× 435 0.9× 233 6.0k
Ki Churl Chang South Korea 47 513 0.4× 3.0k 3.0× 601 0.7× 709 1.0× 337 0.7× 169 6.5k
Mohanraj Rajesh United States 43 250 0.2× 1.8k 1.8× 1.1k 1.2× 224 0.3× 545 1.1× 84 6.1k
Kyung‐Soo Chun South Korea 37 606 0.5× 2.9k 2.9× 465 0.5× 1.1k 1.6× 467 1.0× 101 5.8k
Ali H. Eid Qatar 49 601 0.5× 2.8k 2.8× 743 0.8× 378 0.5× 443 0.9× 250 8.2k

Countries citing papers authored by Othman A. Al‐Shabanah

Since Specialization
Citations

This map shows the geographic impact of Othman A. Al‐Shabanah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Othman A. Al‐Shabanah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Othman A. Al‐Shabanah more than expected).

Fields of papers citing papers by Othman A. Al‐Shabanah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Othman A. Al‐Shabanah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Othman A. Al‐Shabanah. The network helps show where Othman A. Al‐Shabanah may publish in the future.

Co-authorship network of co-authors of Othman A. Al‐Shabanah

This figure shows the co-authorship network connecting the top 25 collaborators of Othman A. Al‐Shabanah. A scholar is included among the top collaborators of Othman A. Al‐Shabanah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Othman A. Al‐Shabanah. Othman A. Al‐Shabanah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Harbi, Naif O., Faisal Imam, Mohammad M. Al-Harbi, et al.. (2022). Protective effect of Apremilast against LPS-induced acute lung injury via modulation of oxidative stress and inflammation. Saudi Journal of Biological Sciences. 29(5). 3414–3424. 3 indexed citations
2.
Alotaibi, Moureq R., Zeinab Hassan, Salim S. Al‐Rejaie, et al.. (2018). Characterization of Apoptosis in a Breast Cancer Cell Line after IL-10 Silencing. PubMed. 19(3). 777–783. 36 indexed citations
3.
Almutairi, Mashal M., Wael A. Alanazi, Musaad A. Alshammari, et al.. (2017). Neuro-protective effect of rutin against Cisplatin-induced neurotoxic rat model. BMC Complementary and Alternative Medicine. 17(1). 472–472. 69 indexed citations
4.
Alhoshani, Ali, Mohamed M. Hafez, Sufia Husain, et al.. (2017). Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats. BMC Nephrology. 18(1). 194–194. 91 indexed citations
5.
Ahmad, Sheikh F., Khairy M. A. Zoheir, Mushtaq Ahmad Ansari, et al.. (2016). Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism. Molecular Neurobiology. 54(6). 4390–4400. 117 indexed citations
6.
Attia, Sabry M., Sheikh F. Ahmad, Mushtaq Ahmad Ansari, et al.. (2016). Utility of Dexrazoxane for the Attenuation of Epirubicin-Induced Genetic Alterations in Mouse Germ Cells. PLoS ONE. 11(9). e0163703–e0163703. 6 indexed citations
7.
Nadeem, Ahmed, Naif O. Al‐Harbi, Mushtaq Ahmad Ansari, et al.. (2016). Psoriatic inflammation enhances allergic airway inflammation through IL-23/STAT3 signaling in a murine model. Biochemical Pharmacology. 124. 69–82. 55 indexed citations
8.
Attia, Sabry M., Sheikh F. Ahmad, Khairy M. A. Zoheir, et al.. (2013). Genotoxic evaluation of chloroacetonitrile in murine marrow cells and effects on DNA damage repair gene expressions. Mutagenesis. 29(1). 55–62. 24 indexed citations
9.
10.
Al‐Shabanah, Othman A., et al.. (2010). Doxorubicin Toxicity can be Ameliorated during Antioxidant L‐Carnitine Supplementation. Oxidative Medicine and Cellular Longevity. 3(6). 428–433. 69 indexed citations
11.
Sayed‐Ahmed, Mohamed M., Abdulaziz M. Aleisa, Salim S. Al‐Rejaie, et al.. (2010). Thymoquinone Attenuates Diethylnitrosamine Induction of Hepatic Carcinogenesis Through Antioxidant Signaling. Oxidative Medicine and Cellular Longevity. 3(4). 254–261. 137 indexed citations
12.
Aleisa, A.M., Salim S. Al‐Rejaie, Saleh A. Bakheet, et al.. (2007). Effect of metformin on clastogenic and biochemical changes induced by adriamycin in Swiss albino mice. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 634(1-2). 93–100. 36 indexed citations
13.
Mansour, Mahmoud, Ayman M. Gamal El-Din, Mahmoud N. Nagi, Othman A. Al‐Shabanah, & Abdullah M. Al‐Bekairi. (2003). Nω-Nitro-L-Arginine Methylester Ameliorates Myocardial Toxicity Induced by Doxorubicin. BMB Reports. 36(6). 593–596. 8 indexed citations
14.
Al‐Majed, Abdulhakeem A., Adel R. A. Abd‐Allah, Ammar C. Al‐Rikabi, Othman A. Al‐Shabanah, & Adel Mostafa. (2003). Effect of oral administration of arabic gum on cisplatin‐induced nephrotoxicity in rats. Journal of Biochemical and Molecular Toxicology. 17(3). 146–153. 64 indexed citations
15.
Khattab, Mahmoud M., Othman A. Al‐Shabanah, & Hassan A. El‐Kashef. (2002). Comparative study of the contractile activity evoked by ATP and diadenosine tetraphosphate in isolated rat urinary bladder. Pharmacological Research. 45(2). 93–99. 6 indexed citations
16.
Al‐Majed, Abdulhakeem A., et al.. (2002). ALPHA-LIPOIC ACID AMELIORATES MYOCARDIAL TOXICITY INDUCED BY DOXORUBICIN. Pharmacological Research. 46(6). 499–503. 34 indexed citations
17.
Mansour, Mahmoud, et al.. (2001). Effects of volatile oil constituents of Nigella sativa on carbon tetrachloride-induced hepatotoxicity in mice: evidence for antioxidant effects of thymoquinone.. PubMed. 110(3-4). 239–51. 154 indexed citations
18.
Al‐Shabanah, Othman A., et al.. (1995). Diltiazem Potentiation of Doxorubicin Cytotoxicity and Cellular Uptake in Ehrlich Ascites Carcinoma Cells. Chemotherapy. 41(5). 368–377. 8 indexed citations
19.
Al‐Shabanah, Othman A., et al.. (1994). Enhancement of Doxorubicin-Induced Cytotoxicity by Hyperthermia in Ehrlich Ascites Cells. Chemotherapy. 40(3). 188–194. 10 indexed citations
20.
Al‐Shabanah, Othman A., et al.. (1989). A selective inhibitor of N8-acetylspermidine deacetylation in mice and hela cells without effects on histone deacetylation. Archives of Biochemistry and Biophysics. 273(1). 128–136. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abul Kalam Najmi Breakdown of academic impact, for papers by Sameer N. Goyal Breakdown of academic impact, for papers by Jae‐Young Um Breakdown of academic impact, for papers by Seyithan Tayşi Breakdown of academic impact, for papers by Siwang Wang Breakdown of academic impact, for papers by Joen‐Rong Sheu Breakdown of academic impact, for papers by Ki Churl Chang Breakdown of academic impact, for papers by Mohanraj Rajesh Breakdown of academic impact, for papers by Kyung‐Soo Chun Breakdown of academic impact, for papers by Ali H. Eid
Rankless by CCL
2026